Gateley - GTLY Share Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Gateley in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" GTLY shares.
View GTLY analyst ratings or view top-rated stocks.

2 equities research analysts have issued 1 year price targets for Gateley's stock. Their GTLY share price forecasts range from GBX 300 to GBX 300. On average, they predict the company's stock price to reach GBX 300 in the next year. This suggests a possible upside of 46.0% from the stock's current price.
View analysts price targets for GTLY or view top-rated stocks among Wall Street analysts.

Gateley's stock was trading at GBX 229.50 at the beginning of 2022. Since then, GTLY shares have decreased by 10.5% and is now trading at GBX 205.50.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, September 1st 2022.
View our GTLY earnings forecast.

Gateley (Holdings) Plc (LON:GTLY) posted its earnings results on Tuesday, December, 5th. The company reported $3.10 EPS for the quarter. The business earned $38.60 million during the quarter.

Gateley declared a dividend on Wednesday, January 12th. Stockholders of record on Thursday, February 17th will be paid a dividend of GBX 3 per share on Thursday, March 31st. This represents a dividend yield of 1.3%. The ex-dividend date is Thursday, February 17th. The official announcement can be accessed at this link.
Read our dividend analysis for GTLY.

Gateley (LON:GTLY) pays an annual dividend of GBX 0.08 per share and currently has a dividend yield of 3.89%. The dividend payout ratio is 62.50%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for GTLY.

Based on aggregate information from My MarketBeat watchlists, some companies that other Gateley investors own include Rose Petroleum plc (ROSE.L) (ROSE), Dynavax Technologies (DVAX), Standard Life Aberdeen (SL), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC), Aviva (AV), BioCryst Pharmaceuticals (BCRX), BioNTech (BNTX), Centamin (CEY) and Countryside Partnerships (CSP).

Gateley trades on the London Stock Exchange (LON) under the ticker symbol "GTLY."

Shares of GTLY stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of GTLY stock can currently be purchased for approximately GBX 205.50.

Gateley (LON:GTLY) has a market capitalization of £255.96 million and generates £133.22 million in revenue each year.

The company employs 1,100 workers across the globe.

Gateley's mailing address is One Eleven, Edmund Street,, BIRMINGHAM, B3 2HJ, United Kingdom. The official website for the company is gateleyplc.com. The company can be reached via phone at 44 121 234 0000.